Bioscript Group launches new AI-augmented platform helping medical affairs teams transform data into action

Symbiosis Formally Presented with Prestigious King’s Award by Lord Lieutenant of Stirling and Falkirk

Biocair France Relocates to Strategic New Facility at Paris-Charles de Gaulle Airport

Biocair, an established global leader in life science logistics, today announced the relocation of its Paris facility to a new, substantially larger premises strategically positioned within the Paris-Charles de Gaulle airport cargo zone.

TeleTracking Launches First AI-Powered Patient Throughput Solution, Decision IQ®

Symbiosis Builds Global Business Development Strength with Two North American Appointments

Nanopath Granted FDA Breakthrough Device Designation for Its Molecular Diagnostic Platform for Urinary Tract Infections

Nanopath, a point-of-care diagnostics company enabling high-quality molecular testing in minutes, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for the company's novel assay for the rapid detection of infection in patients with suspected, or at risk of, complicated urinary tract infections (UTIs).

Verista Sets New Standard for Commissioning, Qualification, and Validation Services in Medical Device Manufacturing

Accelerating medical device validation with digital solutions, risk-based methodology, and proven regulatory expertise.

Zymo Research Announces Strategic Partnership with biomodal to Deliver Next-Gen Multiomic Insights

Zymo Research, a global leader in epigenetics and next-generation sequencing (NGS), has entered a strategic partnership with biomodal, an omics-based life sciences technology and analytics company. As part of biomodal’s certified provider network, Zymo Research’s NGS Services division is now authorized to deliver services using biomodal’s duet multiomics solution evoC and duet multiomics solution +modC, enabling researchers to access comprehensive genetic and epigenetic insights from a single DNA sample.

BioGrad Leads £6 Million Worth PCR Machine Donation to Strengthen UK Science Education

BioGrad is spearheading efforts to place £10.5 million worth of donated PCR equipment by the end of 2025, with £6 million already delivered across the UK.

Integrated DNA Technologies and Beckman Coulter Life Sciences Partner to Advance Cancer Research Through Automated NGS Workflows

Collaboration aims to equip users with complete NGS solution from sample to answer

Advarra and IgniteData announce partnership to simplify clinical trial data transfer for research sites

IgniteData’s Archer platform will connect the site’s EHR system, Advarra’s eSource and EDC systems, and the sponsor’s EDC system of choice, ensuring compatibility between solutions from different vendors.

ThirdLaw Molecular Rebrands as Ladder Bio; Announces $5.5M Seed Financing Led by Medical Excellence Capital and Appoints Eric Heil as Chief Executive Officer

ThirdLaw Molecular, Inc. today announced its new name change, Ladder Bio Inc., reflecting the company’s mission to pioneer Spiroligomer™ therapeutics (“ladder-shaped peptide-like molecules”), a novel therapeutic modality for new medicines. The company name change follows the closing of a $5.5 million Series Seed financing led by Medical Excellence Capital, with participation from Hatch BioFund. The company also announced the appointment of Eric Heil as Chief Executive Officer and the election of David Scheer and Brian Halak, PhD to its Board of Directors.

CluePoints Data and Knowledge Manager Appointed to ACT Editorial Advisory Board

CluePoints, provider of leading statistical and AI-driven software solutions, has announced Sylviane de Viron, its Data and Knowledge Manager, has been appointed to the Applied Clinical Trials (ACT) editorial advisory board.

Abselion Launches His-tagged Protein Quantification Kit and Sensors for Amperia at PEGS Europe 2025

* Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins * Broadens Amperia’s applications across recombinant protein research, screening, and development * Abselion to showcase kit alongside Amperia platform at PEGS Europe in Lisbon, Portugal from 11–13 November

MadeAi™ Unveils New Capabilities for GVD and JCA Reporting, Setting a New Benchmark for Life Science GenAI-Enabled Evidence Synthesis and Reporting

MadeAi launched new capabilities in its MadeAi(TM) GenAI-powered platform for life science evidence synthesis and report generation - capabilities that expedite global value dossier (GVD) and Joint Clinical Assessment (JCA), and streamline literature review from protocol creation to regulatory-ready reporting.

Abzena and Mabqi Announce Strategic Partnership to Offer Integrated Discovery through Development Solution

SPT Labtech and Alithea Genomics Collaborate to Automate Ultra Sensitive Single-Cell Transcriptomic Workflows

Nuclera expands access to eProtein Discovery for APAC customers with distributor agreement in Australia and New Zealand

Partnership with Solve Scientific strengthens international sales as part of ongoing global expansion

DoseMe Acquires Firstline to Build End-to-End Clinical Decision Support for Health Systems in the Global Fight Against Infectious Disease

DoseMe, a global leader in model-informed precision dosing (MIPD) software and a portfolio company of Fairlong Capital, today announced the acquisition of Firstline, a leading clinical decision support platform utilized worldwide. Firstline enables clinicians to rapidly access local, evidence-based infectious disease treatment guidance, susceptibility patterns, and antimicrobial stewardship (AMS) resources. The combination of DoseMe and Firstline creates a single, connected experience from therapy selection through personalized dosing, giving clinicians a faster path to optimal care.

Ambience Healthcare Launches AI-Powered “Conditions Advisor” to Support Comprehensive Inpatient Documentation and High-Quality Care